<u>Ex</u>cisional Treatment&nbsp; <u>C</u>omparison For&nbsp; <u>I</u>n&nbsp; <u>S</u>itu&nbsp; <u>E</u>ndocervical Adenocarcinoma (EXCISE): A Phase 2 Pilot Randomised Controlled Trial to Compare Histopathological Margins Status, Specimen Size and Fragmentation after Loop Electrosurgical Excision Procedure and Cold Knife Cone Biopsy
Paul A. Cohen(The University of Western Australia), C. David Wrede(Royal Women's Hospital), Stuart Salfinger(St John of God Subiaco Hospital), Pennie Stoyles(Australia New Zealand Gynaecological Oncology Group), Louise Farrell(King Edward Memorial Hospital), Lois Eva(University of Auckland), Diane Loh(The University of Western Australia), Colin J.R. Stewart(King Edward Memorial Hospital), Peter Sykes(Christchurch Hospital), Max Bulsara(The University of Notre Dame Australia), Tarryn Nicholson(Auckland City Hospital), Paola Chivers(Edith Cowan University), Stephanie Jeffares(St John of God Subiaco Hospital), Martin R. Stockler, Unine Herbst(Westmead Hospital), Jim Codde(The University of Notre Dame Australia), Bryony Simcock(Christchurch Hospital), Alison H. Brand(The University of Sydney), Yee Leung(King Edward Memorial Hospital), Lyndal Anderson(The University of Sydney), Rachael van der Griend(Canterbury Health Laboratories), Sanela Bilic, Sophie Bittinger(Royal Women's Hospital), Orla McNally(Royal Women's Hospital), Aime Powell(St John of God Subiaco Hospital), Ai Ling Tan(Singapore General Hospital), Julie Silvers(Royal Women's Hospital), Dianne Harker(University of Otago), Ganendra Raj Mohan(St John of God Subiaco Hospital), Adeline Tan(Australia New Zealand Gynaecological Oncology Group)
Cited by 0
Related Papers
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
|Journal of Clinical Oncology|1996|1.6k
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
Driver mutations in <i>TP53</i> are ubiquitous in high grade serous carcinoma of the ovary
|The Journal of Pathology|2010|836
The quanitification of drug caused morbidity and mortality in Australia: Part 1
|UWA Profiles and Research Repository (University of Western Australia)|1995|470
Poor Long-Term Survival in Patients With Moderate Aortic Stenosis
|Journal of the American College of Cardiology|2019|418